Raymond Voltz

Summary

Affiliation: University of Munich
Country: Germany

Publications

  1. ncbi [Paraneoplastic neurological autoimmune diseases]
    R Voltz
    Institut für Klinische Neuroimmunologie, Klinikum Grosshadern, Munchen
    Dtsch Med Wochenschr 129:1743-6. 2004
  2. ncbi Diagnosis and treatment of paraneoplastic neurological disorders
    R Voltz
    Institute of Clinical Neuroimmunology and Department of Neurology, Klinikum Grosshadern, Munchen, Germany
    Onkologie 27:253-8. 2004
  3. ncbi Mitoxantrone therapy in multiple sclerosis and acute leukaemia: a case report out of 644 treated patients
    Raymond Voltz
    Institute of Clinical Neuroimmunology, Klinikum Grosshadern, Munchen, Germany
    Mult Scler 10:472-4. 2004
  4. ncbi Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy
    Raymond Voltz
    Institute of Clinical Neuroimmunology and Department of Neurology, Klinikum Grosshadern, Munich, Germany
    Lancet Neurol 1:294-305. 2002
  5. ncbi [Paraneoplastic neurologic autoimmune diseases]
    R Voltz
    Institut für Klinische Neuroimmunologie, Klinikum Grosshadern, Munchen, Germany
    Nervenarzt 73:909-29. 2002
  6. ncbi [Neuropsychiatric symptoms in palliative care]
    R Voltz
    Neurologische Klinik, Institut für Klinische Neuroimmunologie und Interdisziplinäre palliativmedizinische Einrichtung, Klinikum der Universitat Munchen Grosshadern, Munchen
    Schmerz 15:339-43. 2001
  7. doi Cross-reactive T-cell receptors in tumor and paraneoplastic target tissue
    Hannah L Pellkofer
    Institute of Clinical Neuroimmunology, University Hospital Grosshadern, Ludwig Maximilians University, Munich, Germany
    Arch Neurol 66:655-8. 2009
  8. ncbi Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis
    Rainer Linke
    Department of Nuclear Medicine, Klinikum Grosshadern der LMU, Munich, Germany
    Neurology 63:282-6. 2004
  9. doi Managing non-paraneoplastic Lambert-Eaton myasthenic syndrome: clinical characteristics in 25 German patients
    Hannah L Pellkofer
    Institute for Clinical Neuroimmunology, Ludwig Maximilians University of Munich, 81377 Munich, Germany
    J Neuroimmunol 217:90-4. 2009
  10. doi Favorable response to rituximab in a patient with anti-VGCC-positive Lambert-Eaton myasthenic syndrome and cerebellar dysfunction
    Hannah L Pellkofer
    Institute of Clinical Neuroimmunology, Ludwig Maximilians University, Campus Grosshadern, Marchioninistr 15, D 81377 Munich, Germany
    Muscle Nerve 40:305-8. 2009

Collaborators

Detail Information

Publications28

  1. ncbi [Paraneoplastic neurological autoimmune diseases]
    R Voltz
    Institut für Klinische Neuroimmunologie, Klinikum Grosshadern, Munchen
    Dtsch Med Wochenschr 129:1743-6. 2004
  2. ncbi Diagnosis and treatment of paraneoplastic neurological disorders
    R Voltz
    Institute of Clinical Neuroimmunology and Department of Neurology, Klinikum Grosshadern, Munchen, Germany
    Onkologie 27:253-8. 2004
    ..It is hoped that the recent fundamental advances in understanding the autoimmune pathology of these disorders, especially the role of cytotoxic T cells, will eventually lead to more effective treatment options...
  3. ncbi Mitoxantrone therapy in multiple sclerosis and acute leukaemia: a case report out of 644 treated patients
    Raymond Voltz
    Institute of Clinical Neuroimmunology, Klinikum Grosshadern, Munchen, Germany
    Mult Scler 10:472-4. 2004
    ..This report brings the currently published frequency of MITOX-associated TRAL in MS therapy to five in a total of 2336 treated MS patients, representing an incidence of 0.21%...
  4. ncbi Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy
    Raymond Voltz
    Institute of Clinical Neuroimmunology and Department of Neurology, Klinikum Grosshadern, Munich, Germany
    Lancet Neurol 1:294-305. 2002
    ..The recent fundamental advances in understanding of the autoimmune pathology of these disorders, especially the role of cytotoxic T cells, should eventually lead to more effective treatment options...
  5. ncbi [Paraneoplastic neurologic autoimmune diseases]
    R Voltz
    Institut für Klinische Neuroimmunologie, Klinikum Grosshadern, Munchen, Germany
    Nervenarzt 73:909-29. 2002
    ..These reactions not only prove a paraneoplastic etiology in almost 100% of cases, but, due to their highly specific associations with certain tumor types, also aid tumor detection in patients whose tumor types are not known...
  6. ncbi [Neuropsychiatric symptoms in palliative care]
    R Voltz
    Neurologische Klinik, Institut für Klinische Neuroimmunologie und Interdisziplinäre palliativmedizinische Einrichtung, Klinikum der Universitat Munchen Grosshadern, Munchen
    Schmerz 15:339-43. 2001
    ..Fear and depression must not be overlooked as they may effectively be treated. Suicidal ideation may be dealt with without transfer to a psychiatric ward. Physician assisted suicide is critically discussed...
  7. doi Cross-reactive T-cell receptors in tumor and paraneoplastic target tissue
    Hannah L Pellkofer
    Institute of Clinical Neuroimmunology, University Hospital Grosshadern, Ludwig Maximilians University, Munich, Germany
    Arch Neurol 66:655-8. 2009
    ..According to established criteria, paraneoplastic encephalomyelitis with adrenal neuroblastoma comprises a definite paraneoplastic neurologic syndrome...
  8. ncbi Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis
    Rainer Linke
    Department of Nuclear Medicine, Klinikum Grosshadern der LMU, Munich, Germany
    Neurology 63:282-6. 2004
    ..To assess use of whole-body 18F fluoro-2-deoxy-glucose (FDG)-PET and CT for diagnosing tumor in patients with antibody-positive paraneoplastic neurologic syndromes (PNS)...
  9. doi Managing non-paraneoplastic Lambert-Eaton myasthenic syndrome: clinical characteristics in 25 German patients
    Hannah L Pellkofer
    Institute for Clinical Neuroimmunology, Ludwig Maximilians University of Munich, 81377 Munich, Germany
    J Neuroimmunol 217:90-4. 2009
    ..Furthermore, we discuss the current diagnostic criteria of NT-LEMS...
  10. doi Favorable response to rituximab in a patient with anti-VGCC-positive Lambert-Eaton myasthenic syndrome and cerebellar dysfunction
    Hannah L Pellkofer
    Institute of Clinical Neuroimmunology, Ludwig Maximilians University, Campus Grosshadern, Marchioninistr 15, D 81377 Munich, Germany
    Muscle Nerve 40:305-8. 2009
    ..While conventional immunosuppressive therapy (steroids, azathioprine) failed, he improved with plasma exchange and consecutive treatment with rituximab. Muscle Nerve 40: 305-308, 2009...
  11. ncbi Discontinuation of mechanical ventilation in patients with amyotrophic lateral sclerosis
    G D Borasio
    Department of Neurology, University of Munich, Klinikum Grosshadern, Munchen, Germany
    J Neurol 245:717-22. 1998
    ..If these goals have been met, it may be medically, legally and ethically justified for the physician to take all necessary steps to ensure a peaceful death after discontinuation of life support...
  12. ncbi [Attitudes towards patient care at the end of life. A survey of directors of neurological departments]
    G D Borasio
    Interdisziplinäres Zentrum für Palliativmedizin und Neurologische Klinik, Ludwig Maximilians Universitat Munchen, Munchen
    Nervenarzt 75:1187-93. 2004
    ..Forty-six percent of the respondents believe that their training in end-of-life care was insufficient, and 91% express interest in education programs on palliative care...
  13. ncbi Palliative care in amyotrophic lateral sclerosis
    G D Borasio
    Department of Neurology and Interdisciplinary Palliative Care Unit, University Hospital Grosshadern, University of Munich, Munich, Germany
    Neurol Clin 19:829-47. 2001
    ..Psychological and spiritual care of patients and families are important. Collaboration with hospice institutions and completion of advance directives can be of invaluable help in the terminal phase...
  14. doi Lambert-eaton myasthenic syndrome differential reactivity of tumor versus non-tumor patients to subunits of the voltage-gated calcium channel
    Hannah L Pellkofer
    Institute for Clinical Neuroimmunology, Klinikum Grosshadern, Ludwig Maximilians University, 81377 Munich, Germany
    J Neuroimmunol 204:136-9. 2008
    ..In most cases neurologic symptoms appear before tumor diagnosis, but there is as yet no clear specific serologic marker to distinguish between NT- and T-LEMS...
  15. doi Palliative treatment of chronic neurologic disorders
    Stefan Lorenzl
    Interdisciplinary Center of Palliative Medicine, Ludwig Maximilians University, Munich, Germany
    Handb Clin Neurol 118:133-9. 2013
    ..A palliative approach to neurologic disorders does not simply mean limiting treatment and focusing on pain. Instead, the whole unit of care, consisting of the patient, relatives, and caregivers, should be perceived with all their needs. ..
  16. ncbi Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases
    L A Hoffmann
    Institute of Clinical Neuroimmunology, Ludwig Maximilians University, Munich, Germany
    J Neurol Neurosurg Psychiatry 79:767-73. 2008
    ..The most recently described PNS defining reactivity is anti-Ma/anti-Ta. Here we present 22 newly diagnosed patients with anti-Ma or anti-Ta reactivity, refine the associated clinical picture and review all published patients to date...
  17. ncbi Qualitative evidence of Ri specific IgG-synthesis in the cerebrospinal fluid from patients with paraneoplastic neurological syndromes
    S Jarius
    Institute of Clinical Neuroimmunology, Ludwig Maximilians University, Munich, Germany
    J Neurol Sci 268:65-8. 2008
    ..The pathogenic relevance of these antibodies, however, is further challenged by the finding that specific intrathecal IgG synthesis might not be a prerequisite of CNS involvement, because it was missed in one of our patients...
  18. ncbi The human PNMA family: novel neuronal proteins implicated in paraneoplastic neurological disease
    Martina Schüller
    Department of Clinical Neuroimmunology, Klinikum Grosshadern, Ludwig Maximilians University, Marchioninistr 15, 81377 Munich, Germany
    J Neuroimmunol 169:172-6. 2005
    ..Murine and rat orthologs exist for this protein family. By analogy to the pro-apoptotic MOAP1, similar functional interactions may exist between members of the PNMA family and the bcl-2 family...
  19. doi Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica
    S Jarius
    Institute of Clinical Neuroimmunology, Ludwig Maximilians University, Munich, Germany
    J Neurol Neurosurg Psychiatry 79:1134-6. 2008
    ....
  20. ncbi Specific antibody index in cerebrospinal fluid from patients with central and peripheral paraneoplastic neurological syndromes
    Oliver Stich
    Department of Neurology, Albert Ludwigs University, Freiburg, Germany
    J Neuroimmunol 183:220-4. 2007
    ..These data support the hypothesis that autoimmunity is involved in the pathogenesis of PNS...
  21. doi Spontaneous remission of anti-Ma associated paraneoplastic mesodiencephalic and brainstem encephalitis
    Harald Prüss
    J Neurol 255:292-4. 2008
  22. pmc Anti-Ta-associated paraneoplastic encephalitis with occult testicular intratubular germ-cell neoplasia
    Harald Prüss
    J Neurol Neurosurg Psychiatry 78:651-2. 2007
  23. ncbi Neuropsychological symptoms in paraneoplastic disorders
    Raymond Voltz
    Dept of Palliative Medicine, University Hospital, Kerpener Str 62, 50924, Koln, Germany
    J Neurol 254:II84-6. 2007
    ..As the tumour will not be known in most patients upon presentation to the neurologists, state-of-the art diagnosis including the use of anti-neuronal antibodies and FDG-PET is essential for adequate management of these patients...
  24. ncbi Palliative care in neurology
    Gian Domenico Borasio
    Interdisciplinary Centre for Palliative Medicine, Munich University Hospital, Germany
    J Palliat Care 21:188-9. 2005
  25. ncbi Can antibodies in serum predict the presence of microscopic tumors?
    Raymond Voltz
    Neurology 68:887-8. 2007
  26. ncbi Modelling paraneoplastic CNS disease: T-cells specific for the onconeuronal antigen PNMA1 mediate autoimmune encephalomyelitis in the rat
    Hannah Pellkofer
    Department of Neuroimmunology, Max Planck Institute for Neurobiology, Martinsried, Germany
    Brain 127:1822-30. 2004
    ..This animal model strongly supports the hypothesis that the pathogenesis of paraneoplastic CNS neurological syndromes in man involves an autoimmune T-cell component...
  27. ncbi Novel products of the HUD, HUC, NNP-1 and alpha-internexin genes identified by autologous antibody screening of a pediatric neuroblastoma library
    Uta Behrends
    Hämatologie Onkologie, Kinderklinik der Technische Universität München, Kolner Platz 1, 80804 Munich, Germany
    Int J Cancer 100:669-77. 2002
    ..Our findings indicate that SEREX-defined tumor antigens might provide novel tools for understanding and treatment of this aggressive childhood malignancy...
  28. ncbi Intravenous immunoglobulin therapy in paraneoplastic neurological syndromes
    Raymond Voltz
    Department of Palliative Medicine, University Hospital, Kerpener Str 62, 50924, Koln, Germany
    J Neurol 253:V33-8. 2006
    ..Due to the therapeutic relevance, it is therefore important to diagnose a PND as early as possible, and start immunotherapy including IVIG immediately...